News
After initially refusing to suspend Elevidys distribution after two deaths, Sarepta has now given in to the FDA’s request, ...
The Sarepta saga continues, with the FDA slapping a clinical hold across all of the company’s investigational limb girdle ...
21h
Zacks Investment Research on MSNSRPT Down After Third Death in Muscular Dystrophy Gene Therapy Program
Shares of Sarepta Therapeutics SRPT nosedived 35.9% on Friday following the death of a patient dosed with one of its ...
Sarepta officials said the temporary halt in shipments was done to maintain a productive working relationship with regulators ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results